Clearance Summary
ROCHE DIAGNOSTICS COBAS INTEGRA ALBUMIN GEN. 2 received FDA 510(k) clearance under submission number K033009, sponsored by Roche Diagnostics Corp.. The device was reviewed via the Special premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2003-10-16.
- Submission: K033009
- Applicant / Sponsor: Roche Diagnostics Corp.
- Clearance pathway: Special
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1035
- Decision date: 2003-10-16
Classification & Regulation
This clearance is catalogued under FDA product code CIX and 21 CFR 862.1035, within the Clinical Chemistry review panel as a Class II device.